American Strategic Investment (NYC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Nov, 2025Executive summary
Portfolio consists of six office and retail properties in Manhattan totaling 1.0 million sq ft, with 82% occupancy as of March 31, 2025, and a weighted-average remaining lease term of 5.4 years.
Top 10 tenants are 77% investment grade or implied investment grade, with a 7.8-year average remaining lease term.
Revenue declined to $12.3 million from $15.5 million year-over-year, mainly due to the sale of 9 Times Square.
Net loss attributable to common stockholders was $8.6 million for Q1 2025, compared to $7.6 million in Q1 2024.
Actively marketing 123 William Street and 196 Orchard for sale to unlock value and diversify holdings.
Financial highlights
Q1 2025 revenue was $12.3 million, down from $15.5 million in Q1 2024, mainly due to the sale of 9 Times Square.
Cash net operating income was $4.2 million, compared to $7.0 million in the prior year period.
Adjusted EBITDA was negative $0.8 million, down from $2.9 million in Q1 2024.
Operating expenses decreased to $16.8 million in Q1 2025 from $18.4 million in Q1 2024.
Interest expense declined to $4.1 million in Q1 2025 from $4.7 million in Q1 2024.
Outlook and guidance
Management expects continued challenges in the NYC office market due to slow recovery, high vacancy, and hybrid work trends.
Focus remains on leasing vacant space, managing liquidity, and potential asset sales.
Proceeds from asset sales will be used to retire debt and invest in higher-yielding assets for long-term value.
No debt maturities in 2025; expects to fund operations and capital requirements with cash on hand and cash generated from operations.
Uncertainty remains regarding longer-term liquidity if market conditions do not improve.
Latest events from American Strategic Investment
- $91.9M net loss on $84.7M impairment, $63.5M sale pending, EBITDA and occupancy up.NYC
Q2 20241 Feb 2026 - Q3 net loss rose on impairments; 9 Times Square sale to cut leverage and boost diversification.NYC
Q3 202414 Jan 2026 - Net loss narrowed in Q4 2024 as asset sales improved leverage and a new CEO was appointed.NYC
Q4 202424 Dec 2025 - Annual meeting to vote on director, auditor, and say-on-pay, with all proposals recommended for approval.NYC
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on director, auditor, and executive pay on May 29, 2025.NYC
Proxy Filing1 Dec 2025 - Revenue fell, losses narrowed, and liquidity risks rose as asset sales and foreclosures continued.NYC
Q2 202523 Nov 2025 - Q3 2025 delivered $35.8M net income, stable occupancy, and ongoing liquidity and listing risks.NYC
Q3 202520 Nov 2025